Americans' Savings-Rate Slumps In April As Fed's Favorite Inflation Signal Soars

Acting AG Todd Blanche: Investigating ActBlue Allegations Is A Top Priority The Democratic Party's premier fundraising machine is in serious legal jeopardy, and the new man running the Justice Department just made clear he intends to do something about it. The New York Times reported on Thursday that ActBlue’s own lawyers had warned its leadership in early 2025 that it may have lied to Congress about how it screens out illegal foreign donations.  In 2023, ActBlue CEO Regina Wallace-Jones sent a letter to Republican congressional investigators assuring them the platform used rigorous...

Lavrov Warns Rubio: Get Diplomats & Americans Out Of Kiev Ahead Of 'Systematic Strikes' Russia has again warned Washington to evacuate embassy staff in Kiev as it prepares to launch "systematic strikes" against the Ukrainian capital, in apparent retribution for last week's deadly Ukrainian drone attack on a college dorm in Starobelsk, in Russian-controlled Luhansk Oblast. It is further and more broadly warning all foreign persons to exit the Ukrainian capital, which has already been getting pounded at various intervals, stretching back days. Russia's foreign ministry slammed the college dorm attack, which killed...

GLP-1 Feud Ends: NOVO, HIMS Join Forces (Again) To Sell Obesity Drugs The epic, months-long GLP-1 feud between Novo Nordisk and telehealth firm Hims & Hers Health appears to be coming to a surprising end, with both companies reportedly set to announce, as soon as Monday, a new partnership that would allow the Danish drugmaker to sell Wegovy through HIMS' platform. Bloomberg published the report late Friday, stating: Novo Nordisk A/S plans to sell its weight-loss drugs on Hims & Hers Health Inc.'s platform, according to a person familiar with the matter... ... Novo...